Announcement • 22h
Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 3,333,333
Price\Range: £0.12
Transaction Features: Rights Offering Board Change • May 05
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Nigel Grierson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. New Risk • Apr 10
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of British stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 68% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (UK£12.0m market cap, or US$16.1m). Reported Earnings • Apr 04
First half 2026 earnings released: UK£0.045 loss per share (vs UK£0.028 loss in 1H 2025) First half 2026 results: UK£0.045 loss per share (further deteriorated from UK£0.028 loss in 1H 2025). Net loss: UK£3.14m (loss widened 96% from 1H 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 22 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Dec 25
CEO & Executive Director recently bought UK£100k worth of stock On the 22nd of December, Neil Crabb bought around 645k shares on-market at roughly UK£0.16 per share. This transaction amounted to 16% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Neil's only on-market trade for the last 12 months. Reported Earnings • Dec 09
Full year 2025 earnings released: UK£0.10 loss per share (vs UK£0.02 loss in FY 2024) Full year 2025 results: UK£0.10 loss per share (further deteriorated from UK£0.02 loss in FY 2024). Net loss: UK£6.34m (loss widened 463% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance. Announcement • Dec 09
Frontier IP Group Plc, Annual General Meeting, Dec 31, 2025 Frontier IP Group Plc, Annual General Meeting, Dec 31, 2025. Location: the offices of addleshaw goddard llp, exchange tower, 19 canning street, eh3 9eh, edinburgh United Kingdom New Risk • Oct 12
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Shareholders have been diluted in the past year (23% increase in shares outstanding). Market cap is less than US$100m (UK£11.7m market cap, or US$15.6m). Announcement • Sep 27
Matthew White Decides to Leave as Chief Commercialisation Officer of Frontier IP Group Plc, Effective March 24, 2026 Frontier IP Group Plc announced that Matthew White (Chief Commercialisation Officer) has decided to leave the Group to pursue an opportunity as Chief Executive Officer of a Cambridge based early-stage medical devices company. It is currently intended that Mr. White will remain with the Company as Chief Commercialisation Officer and an Executive Director of the Company until the end of his six month notice period on 24 March 2026. New Risk • Mar 26
New major risk - Revenue size The company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 41% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Shareholders have been diluted in the past year (23% increase in shares outstanding). Market cap is less than US$100m (UK£15.8m market cap, or US$20.4m). New Risk • Jan 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Shareholders have been diluted in the past year (23% increase in shares outstanding). Revenue is less than US$5m (UK£1.9m revenue, or US$2.4m). Market cap is less than US$100m (UK£17.2m market cap, or US$21.5m). New Risk • Jan 17
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 23% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (23% increase in shares outstanding). Revenue is less than US$5m (UK£1.9m revenue, or US$2.3m). Market cap is less than US$100m (UK£17.6m market cap, or US$21.4m). Announcement • Nov 26
Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.47132 million. Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.47132 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 1,683,286
Price\Range: £0.28 Announcement • Nov 24
Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £1 million. Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £1 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 3,571,428
Price\Range: £0.28 Reported Earnings • Nov 24
Full year 2024 earnings released: UK£0.02 loss per share (vs UK£0.059 loss in FY 2023) Full year 2024 results: UK£0.02 loss per share (improved from UK£0.059 loss in FY 2023). Net loss: UK£1.13m (loss narrowed 65% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance. New Risk • Sep 30
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Revenue is less than US$5m (UK£816k revenue, or US$1.1m). Market cap is less than US$100m (UK£18.8m market cap, or US$25.2m). Reported Earnings • Mar 18
First half 2024 earnings released: EPS: UK£0.027 (vs UK£0.005 in 1H 2023) First half 2024 results: EPS: UK£0.027 (up from UK£0.005 in 1H 2023). Net income: UK£1.49m (up 453% from 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance. New Risk • Jan 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Market cap is less than US$100m (UK£25.6m market cap, or US$32.5m). Board Change • Jan 05
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Nigel Grierson was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Recent Insider Transactions Derivative • Dec 04
Key Executive exercised options to buy UK£101k worth of stock. On the 29th of November, James Fish exercised options to buy 250k shares at a strike price of around UK£0.27, costing a total of UK£67k. This transaction amounted to 250% of their direct individual holding at the time of the trade. Since March 2023, James' direct individual holding has increased from 100.00k shares to 350.00k. Company insiders have collectively bought UK£116k more than they sold, via options and on-market transactions, in the last 12 months. Announcement • Nov 29
Frontier Ip Group plc Announces resignation of Jim Fish as Chief Financial Officer Frontier IP Group Plc announced that Jim Fish has notified the Board of his intention to step down as Chief Financial Officer of the Group after 10 years of service. Jim, age 66, will remain as CFO and as a director of the Group through his six month notice period which will end no later than 31 May 2024. Jim will remain focused on running the Group's finance function and continue to support the Group during his six month notice period. Jim will also work to ensure the effective transition of his responsibilities to his successor with the intention that there will be an orderly handover period of three months. Following the appointment of a new Group CFO and the completion of the necessary handover period, Jim will take up a new position within the Group as Portfolio Finance Director where he will continue to support the portfolio companies and will report into the Group CEO. This change is in line with the Group's succession planning and the search for a new Group CFO has been initiated. A further announcement will be made in due course. Announcement • Nov 23
Frontier IP Group Plc, Annual General Meeting, Dec 15, 2023 Frontier IP Group Plc, Annual General Meeting, Dec 15, 2023, at 11:00 Coordinated Universal Time. Location: 93 George Street, Edinburgh, EH2 3ES United Kingdom United Kingdom Agenda: To receive the audited consolidated financial statements of the Company and its subsidiaries for the year ended 30 June 2023, together with the reports of the Directors and the Auditor thereon; to approve the report of the Board to the members on directors' remuneration for the year ended 30 June 2023; to consider Retirement and Re-appointment of Directors; to resolve not to fill the vacancy created by the retirement of Andrew Richmond as a Director and Chairman of the Company at the AGM, in accordance with the Articles of Association of the Company; to re-appoint BDO LLP as auditor of the Company to hold office until the conclusion of the next general meeting at which financial statements are laid before shareholders; to authorize the Directors to determine the auditor's remuneration; to consider Authority to allot shares; and to consider any other matters. Reported Earnings • Nov 02
Full year 2023 earnings released: UK£0.058 loss per share (vs UK£0.19 profit in FY 2022) Full year 2023 results: UK£0.058 loss per share (down from UK£0.19 profit in FY 2022). Net loss: UK£3.24m (down 132% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Announcement • Oct 31
Frontier IP Group plc Announces Board Changes Frontier IP announced that Andrew Richmond, currently Non-Executive Chairman, will be stepping down from the board of Frontier IP having served on the board for more than 11 years. Andrew will remain on the board until the Company's next annual general meeting ("AGM"), expected to be held in December 2023, where he will not seek re-election as a director. Dame Julia King, Baroness Brown of Cambridge, who joined the Frontier IP board of directors in October 2021 and is currently the Senior Independent Director on the board, will assume the role of Chair with effect from the conclusion of the forthcoming AGM. Announcement • Oct 24
Frontier IP Group Plc (AIM:FIPP) acquired 32.8% stake in Deakin Bio-Hybrid Materials Limited. Frontier IP Group Plc (AIM:FIPP) acquired 32.8% stake in Deakin Bio-Hybrid Materials Limited on October 23, 2023. Nick Athanas and George Payne of Allenby Capital Limited acted as financial advisor to Frontier IP Group.
Frontier IP Group Plc (AIM:FIPP) completed the acquisition of 32.8% stake in Deakin Bio-Hybrid Materials Limited on October 23, 2023. New Risk • Oct 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Share price has been volatile over the past 3 months (8.4% average weekly change). Revenue is less than US$5m (UK£2.9m revenue, or US$3.6m). Market cap is less than US$100m (UK£30.1m market cap, or US$36.7m). Reported Earnings • Mar 16
First half 2023 earnings released: EPS: UK£0.005 (vs UK£0.14 in 1H 2022) First half 2023 results: EPS: UK£0.005 (down from UK£0.14 in 1H 2022). Revenue: UK£910.0k (down 93% from 1H 2022). Net income: UK£269.0k (down 97% from 1H 2022). Profit margin: 30% (down from 66% in 1H 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 13% per year. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Julia King was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 27
Full year 2022 earnings released: EPS: UK£0.19 (vs UK£0.17 in FY 2021) Full year 2022 results: EPS: UK£0.19 (up from UK£0.17 in FY 2021). Revenue: UK£14.1m (up 11% from FY 2021). Net income: UK£10.2m (up 6.9% from FY 2021). Profit margin: 73% (down from 76% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Price Target Changed • Apr 27
Price target decreased to UK£1.25 Down from UK£2.00, the current price target is provided by 1 analyst. New target price is 42% above last closing price of UK£0.88. Stock is up 8.1% over the past year. The company posted earnings per share of UK£0.17 last year. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Julia King was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Dec 13
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Julia King was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 29
Full year 2021 earnings released: EPS UK£0.17 (vs UK£0.088 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: UK£12.7m (up 99% from FY 2020). Net income: UK£9.57m (up 129% from FY 2020). Profit margin: 76% (up from 66% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 02
Investor sentiment improved over the past week After last week's 17% share price gain to UK£1.02, the stock trades at a trailing P/E ratio of 10.5x. Average trailing P/E is 19x in the Capital Markets industry in the United Kingdom. Total returns to shareholders of 23% over the past three years. Reported Earnings • Mar 29
First half 2021 earnings released: EPS UK£0.056 (vs UK£0.047 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: UK£4.19m (up 31% from 1H 2020). Net income: UK£3.03m (up 45% from 1H 2020). Profit margin: 72% (up from 65% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Announcement • Mar 12
inSignals Neurotech Receives EUR 100,000 Investment from Portugal Ventures Frontier IP announced that portfolio company inSignals Neurotech has received a €100,000 investment from leading Portuguese venture capital firm Portugal Ventures through its initiative Call INNOV-ID. The funding will be used by inSignals to accelerate the validation and development of its patented technology to aid deep brain stimulation surgery on patients suffering Parkinson's disease. It will also support validation of other applications in neurology. In particular, it will allow the company to expand preliminary clinical trials, strengthen its intellectual property position and grow its team. The Company was selected as a 'one to watch' in the Nature Spinoff Prize 2020 and has already received interest from potential industry partners. It is entering collaboration agreements to extend multi-centre clinical studies in Portugal, the Netherlands, Germany and Spain. Call INNOV-ID is focused on investing in science and technology projects or companies in pre-seed, seed or early stage where the technology is still at a prototype, proof of concept or product market fit validation stage. It was launched in response to a request from the Portuguese government to support technology companies through the COVID-19 pandemic. It is managed by Portugal Ventures, a specialist in seed and early-stage investment in companies operating in digital, engineering and manufacturing, life sciences and tourism, in partnership with ANI, the Portuguese National Innovation Agency, financing specialist PME Investimentos and StartUp Portugal. InSignals' first product is aimed at Parkinson's disease, and has already undergone three clinical studies involving 59 patients. Increased muscle rigidity is one of the key symptoms of the disease and is often treated by implanting deep brain stimulation electrodes when drugs no longer have an effect. InSignals' devices have shown they could help neurologists and neurosurgeons assess rigidity more objectively and place implants more accurately. octors evaluate wrist rigidity during surgery to decide the optimum position for an implant. In some hospitals, two trained surgeons are required to make a judgement by manually manipulating the patient's wrist. This means evaluation can be biased by the physicians' experience and percepion. It can also pose difficulties for younger specialists being trained in the procedure. Other systems designed to provide objective and quantitative evaluation are complicated to set up and are impractical for use during surgical procedures. InSignals' device is easy to set up and use and is currently the only one providing real-time measurements. Potential applications include helping pharmaceutical companies monitor or assess the impact of new or approved drugs in rigidity reduction during clinical trials. InSignals was established to commercialise the work of João Paulo Cunha, Associate Professor with Habilitation at the Department of Electrical and Computer Engineering at the Faculty of Engineering of the University of Porto and senior researcher at the INESC TEC Institute for Systems and Computer Engineering. There, he created the Biomedical Research And INnovation (BRAIN) research group and co-founded the Centre for Biomedical Engineering Research. Is New 90 Day High Low • Mar 05
New 90-day low: UK£0.58 The company is down 10.0% from its price of UK£0.65 on 04 December 2020. The British market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 7.0% over the same period. Is New 90 Day High Low • Feb 04
New 90-day low: UK£0.61 The company is down 6.0% from its price of UK£0.66 on 06 November 2020. The British market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 12% over the same period. Announcement • Feb 02
Frontier IP Supports Breakthrough Technology Frontier IP announced a breakthrough technology to remove the major cause of cork taint in wine from natural corks. The move is a result of collaboration with the Group's partner university, NOVA University of Lisbon - NOVA School of Science and Technology ("FCT NOVA"). Frontier IP supported the Centro de Fisica e Investigação Tecnológica ("CEFITEC") research unit of FCT NOVA in engaging with Amorim to commercialise the new technology. The Group played an important role in negotiating the terms of the commercial agreement, including the licensing terms. Announcement • Jan 17
Frontier Ip Group plc Announces Appointment of Darren Winter Frontier IP announced the appointment of Darren Winter, a former senior sales director with more than 30 years' City experience, as Director of Corporate Relationships, a non-board role. Darren has been appointed to support the Group's portfolio companies with their fundraising requirements. Is New 90 Day High Low • Dec 07
New 90-day low: UK£0.62 The company is down 11% from its price of UK£0.70 on 08 September 2020. The British market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 8.0% over the same period. Reported Earnings • Nov 20
Full year 2020 earnings released: EPS UK£0.088 The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: UK£6.38m (up 49% from FY 2019). Net income: UK£4.18m (up 78% from FY 2019). Profit margin: 66% (up from 55% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Announcement • Nov 20
Frontier IP Group Plc, Annual General Meeting, Dec 17, 2020 Frontier IP Group Plc, Annual General Meeting, Dec 17, 2020, at 11:00 Coordinated Universal Time. Location: 93 George Street Edinburgh United Kingdom Reported Earnings • Nov 06
Full year 2020 earnings released: EPS UK£0.088 The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: UK£6.38m (up 49% from FY 2019). Net income: UK£4.18m (up 78% from FY 2019). Profit margin: 66% (up from 55% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Announcement • Sep 24
An unknown buyer acquired an unknown stake in Frontier IP Group Plc (AIM:FIPP) from IP Group Plc (LSE:IPO). An unknown buyer acquired an unknown stake in Frontier IP Group Plc (AIM:FIPP) from IP Group Plc (LSE:IPO) during the year to date September 10, 2019. During the year, the IP Group Plc has reduced its exposure to OSI and CIC and has exited its small holding in AIM-quoted Frontier IP Group plc, generating total proceeds of £34.9 million.
An unknown buyer completed the acquisition of an unknown stake in Frontier IP Group Plc (AIM:FIPP) from IP Group Plc (LSE:IPO) during the year to date September 10, 2019. 
